Get the Stockscreener App
2.4336
2.11%
0.0636
Mangoceuticals Inc stock is traded at $2.4336, with a volume of 66,421.
It is up +2.11% in the last 24 hours and down -26.37% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$2.37
Open:
$2.43
24h Volume:
66,421
Relative Volume:
0.20
Market Cap:
$6.11M
Revenue:
-
Net Income/Loss:
$-7.32M
P/E Ratio:
-5.56
EPS:
-0.4377
Net Cash Flow:
$-5.99M
1W Performance:
-0.41%
1M Performance:
-26.37%
6M Performance:
-38.89%
1Y Performance:
-72.66%
1-Day Range:
$2.2601
$2.5999
1-Week Range:
$2.10
$2.5999
52-Week Range:
$2.10
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Mangoceuticals Inc Stock (MGRX) Latest News
Head-To-Head Contrast: Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World
Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World
Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World
Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks
Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World
Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World
Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World
Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World
Comparing Mangoceuticals (MGRX) and Its Peers - Defense World
Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World
Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India
Reviewing Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World
Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World
Mangoceuticals (MGRX) versus Its Rivals Head to Head Review - Defense World
Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia
Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com
MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha
Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com
Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com
MangoRx faces lawsuit from Eli Lilly over medication - Investing.com
Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks
MangoRx faces lawsuit from Eli Lilly over medication By Investing.com - Investing.com UK
Critical Contrast: Mangoceuticals (MGRX) and Its Rivals - Defense World
Analyzing Mangoceuticals (MGRX) & Its Rivals - Defense World
Reviewing Mangoceuticals (MGRX) and Its Competitors - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals (MGRX) and Its Competitors Head-To-Head Review - Defense World
Mangoceuticals (MGRX) and The Competition Critical Contrast - Defense World
Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 - Wetaskiwin Times Advertiser
Mangoceuticals (MGRX) versus Its Competitors Financial Contrast - Defense World
Mangoceuticals, Inc. announced that it has received $0.15 million in funding - Marketscreener.com
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga
Contrasting Mangoceuticals (MGRX) and Its Competitors - Defense World
Head-To-Head Comparison: Mangoceuticals (MGRX) & The Competition - Defense World
Examining Mangoceuticals Inc (MGRX) more closely is necessary - US Post News
Mangoceuticals Inc (MGRX) Stock: A Year of Declines and Increases - The InvestChronicle
Upward Trajectory: Mangoceuticals Inc (MGRX) Posts a Slidee, Closing at 0.21 - The Dwinnex
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mangoceuticals Inc Stock (MGRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | Director |
Jun 25 '24 |
Sale |
0.31 |
16,574 |
5,138 |
158,426 |
0.73%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):